AKTSNasdaqPharmaceutical Preparations

Aktis Oncology, Inc. (AKTS) earnings date, market-implied expected move, and options open interest by expiry

15.11

+0.17 · +1.13%

post 15.11 0.00%

After hours16:00 ETdelayed

Open15.62Volume579,700Mkt cap$826.2M

Day14.04 – 15.6268%52-wk13.96 – 34.196%

AKTS

Aktis Oncology, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

—

Calendar

Last report

+4.79%

vs ±17.0% implied · ×0.28

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Largest filed tie

filed ties

13F top-10 QoQ

−2.20%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

113 managers

Top fund weight

0.02%

AKTS weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

No upcoming report date for Aktis Oncology (AKTS). No implied move.

Implied vs realized

3 reports

—≥ implied

Q1 FY26Mar 30 '26confirmed—▲+8.16%—

May 11 '26May 11 '26confirmed—▲+7.99%—

Q2 FY26Aug 13 '26confirmed±17.0%▲+4.79%×0.28

quarterimplied−20%0+20%realized×

Q2 FY26±17.0%▲+4.79%×0.28

May '26—▲+7.99%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 30 close

0.10OI · 3 expiries · Oct 30 closeP/C open interest · Nov 20 · nearest expiry

PUTS · chgexpiry · days · P/CCALLS · chgP/C

660%Nov 2016d638+1%

30%Dec 1844d0.3880%0.38

260%Apr 16163d0.20127+1%0.20

ExpiryPutsCallsP/C

Nov 2016d660%638+1%0.10

Dec 1844d30%80%0.38

Apr 16163d260%127+1%0.20

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−713.48%as filednet margin · revenue +4.87% QoQ · +111.37% YoY

Revenue$3M+4.87%

Gross profit$3M100.00%+4.87%

Operating income−$29M−853.99%−27.27%

Pre-tax income−$24M−31.75%

Net income−$24M−713.48%−31.75%

Cost of revenue$0—

Operating expenses$32M+24.49%

Other income$5M+8.54%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

CPROF ×1.37· ±4.5% vs ±3.2% · 6 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±4.5%4 of 6×1.37

GDPgross domestic product±3.2%8 of 10×0.99

PCEpersonal income & outlays±3.2%8 of 10×0.99

NFPjobs report±2.9%4 of 8×0.91

CPIconsumer prices±2.8%2 of 10×0.85

FOMCrate decision±2.7%4 of 7×0.84

PPIproducer prices±2.7%5 of 11×0.82

Bar = avg |move| to ±5% · tick = ±3.2% avg day · ×base = |move| ÷ ±3.2% · min 6 releases

Earnings history

EPS -0.44 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-0.44	—
Q1 FY26	Mar 30 '26 · confirmed	-0.38	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod